Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31433920

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Aug 22
First author
Chari A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Nov;16(11):661. doi: 10.1038/s41571-019-0275-4.
    note
    Source null
    related pmid
    31485030
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Nov 14;381(20):1977. doi: 10.1056/NEJMc1912625.
    note
    Source null
    related pmid
    31722162
    relationship
    Comment in

Authors and identifiers

  1. name
    Chari A
    type
    Author
  2. name
    Vogl DT
    type
    Author
  3. name
    Gavriatopoulou M
    type
    Author
  4. name
    Nooka AK
    type
    Author
  5. name
    Yee AJ
    type
    Author
  6. name
    Huff CA
    type
    Author
  7. name
    Moreau P
    type
    Author
  8. name
    Dingli D
    type
    Author
  9. name
    Cole C
    type
    Author
  10. name
    Lonial S
    type
    Author
  11. name
    Dimopoulos M
    type
    Author
  12. name
    Stewart AK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Chari A
    type
    Author
  2. name
    Vogl DT
    type
    Author
  3. name
    Gavriatopoulou M
    type
    Author
  4. name
    Nooka AK
    type
    Author
  5. name
    Yee AJ
    type
    Author
  6. name
    Huff CA
    type
    Author
  7. name
    Moreau P
    type
    Author
  8. name
    Dingli D
    type
    Author
  9. name
    Cole C
    type
    Author
  10. name
    Lonial S
    type
    Author
  11. name
    Dimopoulos M
    type
    Author
  12. name
    Stewart AK
    type
    Author
bibliography ids
  1. nci-bib-46c44a32d8fb4dff6b5865ae
book metadata
content sha256
d766599260d7522b1f0f8fd9cc695ba57dc41e6b23f43d4a09b5786d41cbd6d9
document type
citation
dois
  1. 10.1056/NEJMoa1903455
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31433920
immutable id
pubmed:31433920@d766599260d7522b1f0f8fd9cc695ba57dc41e6b23f43d4a09b5786d41cbd6d9
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
727-738
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Nov;16(11):661. doi: 10.1038/s41571-019-0275-4.
    note
    Source null
    related pmid
    31485030
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Nov 14;381(20):1977. doi: 10.1056/NEJMc1912625.
    note
    Source null
    related pmid
    31722162
    relationship
    Comment in
outcomes validated
false
pmid
31433920
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
d92cc1765506b81b8919e85227155307b7919e9d4971e5696787f50b90ff0ed8
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Aug 22
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31433920/
title
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

Preserved source evidence · Not medical advice